A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)

NCT00501046 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1015

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Placebo
DRUG: AST-120

Sponsor

Tanabe Pharma Corporation

Collaborators

[object Object]